Cervicogenic Headache
Investigational adjunct for cervicogenic headache referred from upper cervical (C1-C3) joints; case-series evidence for pain reduction.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for cervicogenic headache. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
- What evidence exists?
- Tier C (investigational). There are no published controlled trials. Evidence-based care for cervicogenic headache (unilateral headache referred from cervical spine structures): structured physical therapy with cervical and thoracic mobilization, suboccipital stretching, cervical strengthening, postural correction, manual therapy combined with exercise (the strongest RCT support), occipital nerve block or facet joint injection for diagnostic and therapeutic purposes, and (refractory) radiofrequency ablation of medial branch nerves. NSAIDs and muscle relaxants help short-term. Workup must exclude secondary headache causes.
- Main risks
- Bleeding from each bite site for 6 to 24 hours after detachment
- Bruising over the upper trapezius or suboccipital region for 5 to 10 days
- Local skin or, rarely, Aeromonas hydrophila infection
- Allergic reaction to leech saliva (uncommon)
- Temporary worsening of headache for 1 to 3 days from local irritation
- RISK if leech is misplaced near the carotid sheath, vertebral artery course, or anterior neck
- Delay of evidence-based physical therapy and occipital nerve block
- Placebo response masking secondary headache causes (intracranial pathology, giant cell arteritis, cervical spine tumor)
- Who should not consider this
- Patients with red-flag headache features (thunderclap onset, neurological deficits, fever with stiff neck, age over 50 with new-onset headache, immunosuppression, cancer history)
- Patients with suspected migraine, cluster headache, or tension-type headache (different treatment paths)
- Patients who have not completed a structured physical therapy program with manual therapy and exercise
- Patients on anticoagulants, with hemophilia, or with severe anemia
- Patients with cervical instability, recent neck trauma, or vertebrobasilar insufficiency
- Patients with active dermatitis or broken skin over the cervical or suboccipital region
- What to ask your clinician
- Have we excluded migraine, cluster headache, tension-type headache, and secondary headache causes?
- Have I had imaging if there are any red flags or atypical features?
- Have I completed a structured physical therapy program with manual therapy and cervical strengthening?
- Have I tried occipital nerve block or facet joint injection - both diagnostic and therapeutic?
- Am I a candidate for radiofrequency ablation of medial branch nerves for refractory cases?
- Where exactly will leeches be placed - confirm strictly over upper trapezius or suboccipital region, NEVER on anterior neck?
- What is the Aeromonas-prevention protocol?
- When to seek urgent care
- Thunderclap (worst-of-life) headache, sudden severe headache (possible subarachnoid hemorrhage - 911)
- Headache with fever, stiff neck, photophobia, or altered mental status (possible meningitis)
- Sudden vision change, speech difficulty, focal weakness, or seizure
- Jaw claudication, scalp tenderness, or vision change in age over 50 (possible giant cell arteritis)
- New-onset headache during pregnancy or postpartum
- Bleeding from a bite site lasting more than 24 hours
- Hives, facial or throat swelling, or breathing difficulty
What this does NOT mean
- This is not FDA-cleared for cervicogenic headache.
- No controlled trials support efficacy; cervicogenic headache responds best to manual therapy plus exercise.
- It does not replace occipital nerve block or facet joint injection - both have stronger evidence and are diagnostic.
- It does not address red-flag features that require imaging and specialist referral.
- Headache types overlap; misdiagnosis is common and treatment of the wrong type wastes time.
Safety cross-references
Clinical Profile
- Category
- neurological
- ICD-10
- G44.86, M54.2
- Safety tier
- medium
Evidence Summary
Cervicogenic headache is defined per ICHD-3 criteria as headache caused by a disorder of the cervical spine and its component bony, disc, or soft-tissue elements (most commonly the C1-C3 zygapophyseal joints). Diagnosis is supported by a diagnostic anesthetic block. Conventional management includes manual therapy, motor-control exercises, and image-guided cervical facet or C2 dorsal ramus block. No controlled clinical trial or published case series of leech therapy for cervicogenic headache has been reported; any use is investigational and mechanistic only and should not replace established care.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Key Trials
- Ahmed I et al. (2020), n=24
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Vertebrobasilar insufficiency
- Cervical instability (Down syndrome, RA, traumatic ligamentous injury)
- Recent cervical facet injection (<4 weeks)
Related Conditions
Cervical Radiculopathy
Off-label use with one RCT (Michalsen 2018) showing significant pain reduction at 7 days in cervical radiculopathy without surgical indication.
Lumbar Radiculopathy (Sciatica)
Off-label use with controlled trial evidence (n=80) showing leg pain and Oswestry score improvement at 4-12 weeks in non-surgical lumbar disc disease.
Migraine
Investigational use with case-series evidence for reduction of migraine frequency and intensity; mechanism plausible via reduction of cervico-cranial venous congestion.
Tension-Type Headache
Investigational use with small case series suggesting frequency reduction in chronic tension headache via reduction of pericranial muscle tension and venous congestion.